For AI assistants & researchers — machine-readable summary of this page
What this page is: Delvantic's full research page for Nice Ltd. (NICE) — AI-driven forensic equity research: mechanical valuation models (DCF, EPV, anchored-PE, scenario) plus three independent AI lenses (Quality / Value / Sentiment). Everything below is rendered server-side; you are not missing content that requires JavaScript. All scores are predictions and research opinions, not financial advice.
Our current read (analysis of 2026-08-23): Designation Gem · Gem Score +61 (−100…+100 Quality+Value blend) · Quality 80 · Value 46 · Sentiment -56 (timing only, not weighted) · Composite fair value $197.48 vs $100.52 at analysis
Page map (sections in order; each card carries a stable
reference-name attribute you can cite):
profile-header/price-overview— company profile, live quote, market capextended-analysis— the core: three AI lens reads with findings, scores, and the analyst memofuture-predictions— our forward price-band predictionsmarket-narrative/ai-findings/gpt-critique— narrative context, cross-model findings, and an adversarial critique of our own analysis (near the end of the document)- Members-only sections (render as login gates for anonymous readers):
price-history,income-trend,key-metrics,financials(statement tables),insider-trading. The analysis above is public; the raw data tables require a free account.
More for machine readers: site briefing at
/llms.txt ·
any ticker resolves at delvantic.com/stock/TICKER ·
raw inputs are public-company filings and market data (via licensed data feeds);
every model, score, lens read, and prediction on this page is Delvantic's own analysis.
Nice Ltd.
NICE NASDAQNice Ltd. Sponsored ADR represents shares of NICE Ltd., an Israel-based enterprise software company focused on AI-powered cloud platforms for customer engagement and financial crime and compliance. The company operates primarily through two business segments: Customer Engagement and Financial Crime and Compliance. In customer engagement, NICE delivers CXone and related applications that support contact centers and digital interaction channels with capabilities such as call routing, self-service, workforce engagement, and analytics to optimize customer experience and operational efficiency. In financial crime and compliance, it provides embedded-AI solutions that help financial institutions detect and prevent money laundering, fraud, and trading abuses, while supporting regulatory reporting and surveillance. NICE also offers digital evidence management and investigation tools for public safety and justice agencies. Incorporated in 1986 and headquartered in Ra’anana, Israel, Nice Ltd. Sponsored ADR gives global investors exposure to a technology provider serving enterprises, financial institutions, and public sector organizations across the United States, Europe, the Middle East, Africa, and Asia-Pacific.
Price Overview
Price History (1 Year)
Revenue & Net Income Trend
Nice Ltd. is a foreign private issuer — it reports to the U.S. SEC once a year (on Form 20-F or 40-F) rather than filing the quarterly statements (10-Q) that U.S.-domiciled companies must submit. Our financial statements are read directly from SEC filings, so for this company only annual figures exist at the source.
This is a property of how the company files, not missing or broken data — its filing history shows 16 annual reports, the latest filed 2026-02-26, and no quarterly filings . The company may still publish quarterly results on its own investor-relations site.
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
EPS (Diluted): 9.67
Total Equity: $3.88B
Shares: 63,323,000
Total Debt: $0.00
Cash: $379.39M
EBITDA: $844.80M
Total Debt: $0.00
Cash: $379.39M
Revenue: $2.95B
Revenue: $2.95B
Revenue: $2.95B
Total Equity: $3.88B
Tax Rate: 13.1%
Equity: $3.88B
Total Debt: $0.00
Cash: $379.39M
Current Liabilities: $887.63M
Long-Term Debt: $0.00
Total Debt: $0.00
Total Equity: $3.88B
Shares: 63,323,000
Shares: 63,323,000
CapEx: -$18.92M
Shares: 63,323,000
Stock Price: $98.64
Net Income: $612.10M
Industry Benchmarks
Income Statement (Annual)
Last updated: Aug 12, 2026 12:50pm (11d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $1.9B | $2.2B | $2.4B | $2.7B | $2.9B |
| Cost of Revenue | $624.5M | $683.7M | $768.2M | $909.5M | $989.3M |
| Gross Profit | $1.3B | $1.5B | $1.6B | $1.8B | $2.0B |
| Operating Expenses | $1.0B | $1.2B | $1.2B | $1.3B | $1.3B |
| Operating Income | $263.9M | $335.2M | $435.2M | $546.0M | $645.8M |
| Net Income | $199.6M | $265.1M | $336.5M | $439.5M | $612.1M |
| EBITDA | $448.0M | $511.7M | $602.6M | $751.0M | $844.8M |
| EPS | $3.15 | $4.17 | $5.32 | $6.97 | $9.82 |
| EPS (Diluted) | $2.98 | $4.00 | $5.11 | $6.76 | $9.67 |
Balance Sheet (Annual)
Last updated: Aug 12, 2026 12:50pm (11d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $378.7M | $529.6M | $511.8M | $481.7M | $379.4M |
| Total Current Assets | $2.3B | $2.4B | $2.3B | $2.5B | $1.4B |
| Total Assets | $4.7B | $4.9B | $5.1B | $5.3B | $5.1B |
| Current Liabilities | $1.3B | $1.1B | $1.1B | $1.5B | $887.6M |
| Long-Term Debt | $429.3M | $455.4M | $457.1M | $0 | — |
| Total Liabilities | $1.9B | $1.8B | $1.8B | $1.7B | $1.2B |
| Total Equity | $2.8B | $3.1B | $3.4B | $3.6B | $3.9B |
| Retained Earnings | $1.7B | $1.9B | $2.3B | $2.7B | $3.3B |
Cash Flow (Annual)
Last updated: Aug 12, 2026 12:50pm (11d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | $461.8M | $479.7M | $561.4M | $832.6M | $716.5M |
| Capital Expenditure | -$24.8M | -$31.9M | -$29.2M | -$35.0M | -$18.9M |
| Free Cash Flow | $437.0M | $447.8M | $532.2M | $797.7M | $697.6M |
| Acquisitions (net) | — | — | -$415.2M | -$64.8M | -$856.1M |
| Net Debt Issued / (Repaid) | -$177.3M | -$20.1M | -$2.6M | -$192.1M | -$460.0M |
| Dividends Paid | — | — | — | — | — |
| Stock Buybacks | -$73.2M | -$144.9M | -$288.4M | -$369.2M | -$488.9M |
| Net Change in Cash | -$63.6M | $154.4M | -$19.8M | -$28.3M | -$103.0M |
Growth Trends (YoY %)
Last updated: Aug 12, 2026 12:50pm (11d ago)| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue Growth | +13.5% | +9.0% | +15.0% | +7.7% |
| Gross Profit Growth | +15.5% | +7.5% | +13.4% | +7.1% |
| Operating Income Growth | +27.0% | +29.9% | +25.4% | +18.3% |
| Net Income Growth | +32.8% | +26.9% | +30.6% | +39.3% |
| EBITDA Growth | +14.2% | +17.8% | +24.6% | +12.5% |
Dividend History (Last 20)
Last updated: Aug 12, 2026 12:50pm (11d ago)| Date | Dividend | Declaration | Record | Payment |
|---|---|---|---|---|
| 2017-02-23 | $0.16 | — | — | — |
| 2016-11-18 | $0.16 | — | — | — |
| 2016-08-11 | $0.16 | — | — | — |
| 2016-05-19 | $0.16 | — | — | — |
| 2016-02-22 | $0.16 | — | — | — |
| 2015-11-06 | $0.16 | — | — | — |
| 2015-08-07 | $0.16 | — | — | — |
| 2015-05-18 | $0.16 | — | — | — |
| 2015-02-13 | $0.16 | — | — | — |
| 2014-11-13 | $0.16 | — | — | — |
| 2014-08-08 | $0.16 | — | — | — |
| 2014-05-22 | $0.16 | — | — | — |
| 2014-02-13 | $0.16 | — | — | — |
| 2013-11-07 | $0.16 | — | — | — |
| 2013-08-20 | $0.16 | — | — | — |
Deep Analysis
Narrative Economics
market-narrative step).
AI Lens 4th lens · how AI reaches this business · 5-yr
2026-08-13Cheap voice and language models let NICE convert deflection into a consumption-priced product it already has distribution for — CXone Mpower orchestration, QA of AI agents, and automated self-service sold into thousands of installed enterprise contact centers that no AI-native startup can reach quickly; meanwhile its own support, professional-services and analytics delivery costs fall.
The historical unit of monetization is the human agent (and workforce-management/QA seats attached to that human). Every percentage point of calls handled by an autonomous agent removes billable seats faster than consumption revenue replaces them, and generic LLMs already do transcription, summarization, sentiment and script adherence — the features NICE priced as premium analytics.
Whether revenue per customer holds as seats fall — i.e. does AI/self-service ARR grow faster than seat attrition. The observable is CXone/cloud ARR growth versus total seat counts and net revenue retention, plus whether NICE stops disclosing seat-linked metrics.
Actimize's model-validation, audit-trail and regulator-accepted AML/fraud tooling with named liability; compliant call recording and multi-year retention obligations; deep CTI/telephony and workforce-scheduling integrations inside large regulated enterprises.
AI Lens thesis
The need — resolving customer problems at scale and detecting financial crime — is permanent, but NICE's solution layer splits in two under cheap intelligence. In customer engagement, AI attacks both the priced unit (human seats) and the differentiated feature set (interaction analytics, QA, routing logic), while lowering the barrier for AI-native entrants and letting CRM/hyperscaler platforms own the conversation layer and push NICE toward backend recording and reporting; the company's defense is installed-base distribution, orchestration/governance of hybrid human-plus-AI workforces, and repricing to consumption. In financial crime, cheap intelligence is mostly an input that improves detection while the regulatory responsibility NICE absorbs stays scarce, so pricing there should hold or improve. The 2021-25 record — 67.5%-to-66.4% gross margin drift, 13.7%-to-21.9% operating margin, $698M FCF — shows real AI-era cost leverage already landing, but 7.7% growth against a 12.0% industry says the top line is where the damage is showing up first.
What the market may be underestimating
Upside Governance of AI agents may be a bigger annuity than human WFM ever was — enterprises will need auditable QA, escalation logs and regulator-defensible records of what an autonomous agent said, and NICE's Actimize/compliance DNA is unusually well positioned to sell that as the liability layer for other vendors' bots.
Downside Cost leverage can mask price erosion: operating margin can keep expanding on AI-driven service and R&D efficiency for several years while per-interaction pricing and seat counts quietly compress, so the deterioration shows in bookings and NRR long before it shows in EPS.
Outcome range spread 57 · unresolved
Growth Outlook
Analyzed 2026-08-20 16:05The question every valuation on this page silently assumes: is this company likely to grow? Judged forward — the business, its category, the world — against what's already printed.
Claude Reading
Starting with the raw tape: NICE compounded revenue from $1.92B (2021) to $2.95B (2025) — an 11.3% CAGR — while operating income more than doubled from $264M to $646M and net income tripled from $200M to $612M. Operating margin expanded from 13.7% to 21.9%, and FCF hit $698M on $19M capex (a 23.7% FCF margin). Balance sheet is pristine: zero debt, $379M cash, $3.88B equity. At $101 and a $5.91B market cap, this trades at 10.5x earnings, 8.5x FCF, and roughly 7x EV/EBITDA. For a debt-free, 66% gross margin software business still growing double digits with 16% ROIC, that is objectively cheap on any historical software comparison — Five9 and Genesys peers trade at multiples of this on FCF. The 2025 YoY earnings growth of 39% versus 7.7% revenue growth is the tell: operating leverage is real, not a one-time item, since it's the fourth consecutive year of margin expansion.
Where I disagree with the prior stack: the synthesis "composite fair value $197 → signal-adjusted $314" is nonsense — that's a 3x from spot on a company growing 8% at the top line, and it discredits the composite. Ignore it. The Thesis Evaluation's -6 score (near-neutral) is closer to right but leans too bearish given the actual print. The Market Forces "margin expansion is unsustainable" claim needs interrogation: 800bps of op margin expansion over four years while revenue grew 54% suggests genuine scale economics, not accounting games — OCF of $716M against $612M net income is a 1.17x conversion, which is healthy, not deteriorating. The Narrative layer's "cash-flow deterioration" framing contradicts the actual FCF CAGR of 14.5%. Someone is looking at a different company, or confusing the stock chart (down from $154 to $101) with the financials (up and to the right).
The contrarian case that actually has teeth is not "hidden economic deterioration" — it's competitive displacement risk that hasn't hit the P&L yet. Contact center as a service is a battleground where Salesforce (Service Cloud + Agentforce), Microsoft (Dynamics + Copilot), and Amazon Connect can bundle AI-native agents at near-zero marginal cost. NICE's CXone is the incumbent but incumbents in bundled-vs-standalone software fights historically lose 200-400bps of growth per year for 3-4 years before it shows in reported revenue — deferred revenue and multi-year contracts mask it. The 7.7% recent YoY versus 11.3% four-year CAGR is the first whiff. Financial Crime (Actimize) is stickier but smaller. The other genuine risk: at $5.91B market cap on $612M NI, if growth decelerates to 3-4% and margins mean-revert 200bps, you're looking at a $500M earnings base and a 12x multiple is generous — that gets you to $85, not $60. So downside is bounded.
Insider data is stale and thin (2026 dates on a tiny option exercise/sale — noise). No signal there. My read: the synthesis "fair value" verdict is directionally right but its numeric anchors ($197, $314) are unusable. I dissent from the composite fair value math but agree the stock is not overvalued. On my own numbers — 8% revenue growth, flat-to-slightly-expanding margins, $700M+ FCF, zero debt — a 14-16x FCF multiple (still a discount to software peers) gets you $9.8-11.2B EV, or $165-190 per share. Even haircutting for competitive risk with a 12x FCF multiple gives $140. Current $101 is pricing in genuine terminal-decline pessimism that the numbers don't yet support. This is undervalued with a real-but-not-fatal execution overhang; a starter position at $101 with adds under $90 makes sense, and the re-rating catalyst is one clean quarter showing CXone growth stabilizing above 8%. If the next print shows CXone decelerating below 6%, the bear case gets credibility and $85 is in play.
GPT Reading
What jumps out is how dislocated the valuation is from the reported economics. NICE has gone from $1.92B of revenue in 2021 to $2.95B in 2025, an 11%+ CAGR, while operating income climbed from $263.9M to $645.8M and net income from $199.6M to $612.1M. That is not a melting-ice-cube profile. Operating margin expanded from 13.8% to 21.9% in four years, net margin from 10.4% to 20.8%, and free cash flow reached $697.6M in 2025 against $612.1M of net income. On a $5.91B market cap, that is roughly an 8.5x trailing FCF multiple and about a 10.5x P/E for a debt-free software company with 66.4% gross margins and 16% ROIC. If those numbers are even broadly sustainable, the stock is plainly cheap.
The balance sheet reinforces that view. NICE has zero debt, $379.4M of cash, and $3.88B of equity, so this is not a case where a low multiple is masking leverage risk or capitalized software fantasy economics. EV/revenue at about 2.0x and EV/EBITDA at 7.0x are industrial-company multiples being applied to a software asset that is still growing revenue high single digits and earnings nearly 40% year over year. Even if you haircut the 2025 earnings growth as unusually strong, the valuation still implies either a sharp deterioration in margins, a coming revenue stall, or both. I do not see that deterioration in the actual trend supplied here. Quite the opposite: revenue rose every year, gross profit rose every year, operating profit rose faster than revenue, and cash conversion remains excellent given capex is only $18.9M.
I also think some of the model output is overfitting a narrative of “fallen angel” software skepticism onto data that simply does not support deep distress. The idea that cash conversion has “collapsed” is hard to reconcile with $716.5M of operating cash flow and $697.6M of free cash flow in 2025. The rule-based “mature earner” label is directionally right in one sense — this is no longer a hypergrowth SaaS name — but the market appears to be treating mature as synonymous with ex-growth or structurally impaired. A business growing revenue 7.7% and earnings 39.3% most recently, with 20%+ operating margins and no debt, should not trade like a challenged legacy software vendor unless there is a very real fear that 2025 is peak profitability. My read is that the market is extrapolating competitive anxiety far more aggressively than the financials justify.
The best case against this view is straightforward: 7.7% revenue growth is not special in software, and if NICE is now a lower-growth enterprise platform facing CCaaS and AI competition, then today’s margins may be near cyclical highs rather than a base to build from. Gross margin at 66.4% is good but not elite for software, which can indicate services mix, pricing pressure, or less-scalable delivery economics. The multiple could also be “correct” if reported earnings are benefiting from favorable mix or temporary operating discipline while the core franchise is slowly losing strategic relevance. A skeptic would say that 2.0x EV/revenue is what the market pays for a vendor with okay current numbers but limited confidence in durable double-digit growth, especially if the contact-center stack is becoming more contestable and AI threatens to flatten differentiation. I take that seriously, and it is why I am not arguing for a premium SaaS multiple; I am arguing that even a modest re-rating to 12x-14x FCF or earnings would justify materially higher prices than $101.
What would change my mind is evidence that 2025 was a profit peak masking a weakening top line. If annual revenue growth slips below 5% while operating margin retreats from 21.9% toward the mid-teens, the cheapness is a value trap and the current multiple is deserved. Likewise, if free cash flow falls materially below net income for more than a year — say FCF under $550M without a clear one-time reason — that would undermine the core quality argument. Absent that, I think the burden of proof is on the bears: a debt-free software company producing roughly $700M of FCF on $2.95B of sales should not be stuck near 8x-10x cash earnings unless deterioration is imminent, and the data here do not show imminence.
Grok Reading
NICE at $101 prints a free-cash-flow yield of roughly 11.8 percent on $697.6 million of 2025 FCF against a $5.91 billion equity value, with zero net debt and a fortress balance sheet ($379 million cash, no leverage). That cash engine sits on a business that just delivered $2.95 billion of revenue, up from $2.74 billion and $2.38 billion the two prior years, while net income scaled from $336.5 million to $439.5 million to $612.1 million. Operating margin expanded to 21.9 percent and net margin to 20.8 percent; ROIC sits at 16 percent. The market is capitalizing this at 10.5× trailing earnings, 2.2× sales and 7.0× EV/EBITDA. Those multiples imply the franchise is in managed decline. The income statement does not: earnings CAGR of 35 percent over five years and a 39 percent jump in the latest year show operating leverage still working, even as top-line growth has cooled to a 7.7 percent recent clip from an 11.3 percent longer-term CAGR.
What stands out is the gap between cash reality and the pricing. Capex is a trivial $19 million; virtually all operating cash converts. Gross margin holds at 66 percent. Equity of $3.88 billion against a market cap of $5.91 billion produces a 1.65× book multiple that would be unremarkable for a slow industrial and is absurd for a software platform still compounding double-digit earnings. The quantitative composite that spat out mid-$190s to low-$300s fair value is directionally right on the cash flows even if the upper bound is aggressive; the 10× multiple is the anomaly, not the DCF. Rule-based labeling as a “mature earner” is correct on the surface, yet mature earners with 20 percent net margins, zero debt and high-teens ROIC do not trade at single-digit free-cash-flow multiples unless the market has already decided the moat is gone. The data have not yet confirmed that decision.
The strongest opposing case is straightforward and has real teeth. Revenue growth has decelerated into the high single digits while the contact-center and customer-engagement TAM is being contested by Five9, Genesys, Salesforce and the hyperscalers; if share is leaking, the 7.7 percent print is the start of a worse slope, not a trough. The narrative layer flags acquisition integration noise (Enlighten and others) and questions whether the AI layer is defensible or merely table stakes that compress pricing. Margin expansion of this magnitude can mean one-time mix or cost cuts rather than durable operating leverage, and any reversion toward mid-teens operating margins would erase a large part of the earnings beat that makes the multiple look cheap. Cash conversion is pristine this year, but skeptics will note that a single year of strong FCF does not prove the economic model if deferred revenue or working-capital timing is flattering the print. The 34 percent drawdown from $154 and the “fallen angel” framing exist because growth disappointed relative to the prior SaaS premium; cheap can stay cheap if the top line stalls near 5 percent.
I weigh the bear case as real risk but secondary to the current cash yield and balance-sheet optionality. A debt-free software company throwing off nearly $700 million of FCF does not need heroic growth to justify a price well above $101; even a fade to mid-single-digit revenue growth with stable 18–20 percent net margins supports a mid-teens earnings multiple and material upside. The market is underwriting something closer to structural impairment. That is a higher bar than the recent numbers clear.
Two concrete flips would reverse the view: trailing twelve-month revenue growth settling sustainably below 5 percent with concurrent operating-margin compression below 18 percent, or clear evidence of share loss in the core CXone franchise against hyperscaler bundles. Conversely, a re-acceleration above 12 percent organic growth with FCF holding above $650 million would force a sharp re-rating and validate the higher end of the valuation composites.
Big-3 Panel — where each AI stands
Advanced Analysis Forensic deep-dive · separate lenses
NICE shows a textbook mature software profile: revenue grew from $1.92B (2021) to $2.95B (2025), a ~11% CAGR, while operating margin expanded steadily from 13.7% to 21.9% and net income tripled from $199.6M to $612.1M. Gross margin held in a tight 66-69% band, which is consistent with a durable software mix rather than a deteriorating one. FCF rose from $437M to $697.6M (peaking at $797.7M in 2024), and OCF/NI of 1.77x plus accruals of -4.8% of assets indicate earnings are backed by cash, not accounting stretch. Beneish M of -2.19 and Altman Z of 4.9 corroborate clean books and solvency. Capital allocation is a real positive: diluted shares fell from 66.9M to 63.3M (-1.4% CAGR) with buybacks at 162% of SBC (5% of revenue), so per-share value is being concentrated. Net cash of $417M and self-funded operations mean no dependence on capital markets. The one caveat versus a fortress rating is scale/moat inference: cash/mktcap at 7.1% is modest, gross margin is good-not-elite for software, and the insider tape is neutral-to-slightly-negative (one small sale, zero buys). Nothing here looks broken; it simply doesn't reach the 'essentially nothing soft' tier.
Verify before trusting this (5)
- Customer concentration and net revenue retention disclosure in the 10-K/20-F to confirm moat durability
- Segment mix shift between cloud/CCaaS and legacy on-prem — is cloud growth offsetting on-prem decline healthily?
- Detail on any acquisition-related intangibles or capitalized software affecting reported margins
- Any convertible debt or off-balance-sheet obligations behind the reported net cash figure
- Management commentary on AI competitive positioning versus new CCaaS entrants
The e2e composite fair value of $197 and signal-adjusted $314 both look aggressive — I'd discount the signal-adjusted number as a runaway output (a 3x fair value on a mature large-cap software name almost never holds). But the DCF at $250 and EPV floor at $91 bracket a defensible deserved-value range of roughly $130-$180 for a business compounding revenue double digits with expanding margins, >1x cash conversion, contained SBC, and net buybacks. Against $100.84, that implies a 25-45% gap — a real, if not extraordinary, margin of safety.
Verify before trusting this (5)
- organic vs acquired revenue growth split
- CCaaS segment ARR growth and net retention trend
- Enlighten AI revenue contribution and gross margin
- FY guidance for operating margin trajectory
- buyback pace vs SBC dilution net effect
The broad tape is mildly risk-on (VIX 14.9, S&P near highs), but with a beta of 0.04 that macro tailwind essentially does not reach NICE — this name trades on its own story, and the story is a fragile fallen-angel arc. The narrative frame (moderate intensity, low cult, fragile durability) is the classic 'cheap for a reason' setup where every positive print gets sold and every ambiguous tape day gets faded, exactly what the recent big-move log shows: a 22.5% guidance-driven gap in May, a sell-the-news 3.8% drop on an actual Q2 beat, and an unexplained 4.3% drift-down on Aug 17. That is a tape where sentiment is not letting the fundamentals breathe. The one-off Bluecrest customer-win headline is genuinely positive but small-caliber and unlikely to shift the dominant frame. Analyst tone and target revisions have followed the guide-down, so estimate momentum is still a headwind even as the AI-bookings sub-narrative tries to form a counter-story. Net: non-fundamental pressure leans negative but not violently so — a persistent press, not a collapse.
Verify before trusting this (4)
- Next guidance update — does management reset the bar low enough to enable a beat-and-raise, breaking the sell-the-news pattern?
- AI ARR growth trajectory over the next 1-2 prints — sustained >40% would let the counter-narrative gain durability
- Analyst target revisions — watch for the first upgrade cycle, which typically marks the sentiment inflection for fallen-angels
- Any competitive win/loss disclosures vs Salesforce or hyperscaler CX offerings that would validate or refute the commoditization bear thesis
The need — resolving customer problems at scale and detecting financial crime — is permanent, but NICE's solution layer splits in two under cheap intelligence. In customer engagement, AI attacks both the priced unit (human seats) and the differentiated feature set (interaction analytics, QA, routing logic), while lowering the barrier for AI-native entrants and letting CRM/hyperscaler platforms own the conversation layer and push NICE toward backend recording and reporting; the company's defense is installed-base distribution, orchestration/governance of hybrid human-plus-AI workforces, and repricing to consumption. In financial crime, cheap intelligence is mostly an input that improves detection while the regulatory responsibility NICE absorbs stays scarce, so pricing there should hold or improve. The 2021-25 record — 67.5%-to-66.4% gross margin drift, 13.7%-to-21.9% operating margin, $698M FCF — shows real AI-era cost leverage already landing, but 7.7% growth against a 12.0% industry says the top line is where the damage is showing up first.
Verify before trusting this (8)
- Disclosed shift to consumption pricing
- Net revenue retention trajectory
- Revenue per customer vs seats
- Seat counts vs interaction volumes
- Mix of WFM/QA revenue in guidance
- Self-service containment rates disclosed
- Analytics module pricing/discounting
- Model inference cost in gross margin
The world is re-pricing customer engagement from headcount-augmentation to interaction-automation. That is simultaneously the largest new TAM NICE has ever addressed and the direct solvent for its seat-based unit. Regulatory intensification in financial crime cuts the other way — more scrutiny means more auditable, vendor-supplied surveillance, and that revenue is macro-insensitive. Net: the category keeps growing, but the unit of monetization is being renegotiated mid-flight, and incumbents with installed bases get first option on the new unit while carrying the old one's decay.
When we made this prediction on Aug 21, 2026, NICE was $101.13. We expect it to be $132.00 by Feb 2027, and we consider it great value under $95.00. This is an early model (v0.6.0) — the direction is more reliable than the exact price. Made Aug 21, 2026.
Blue is our prediction, starting the day we made it. Grey is a slower route to the same place — the same destination, taking longer. Black is the actual price, so you can see how we are doing.